glp-1 gi obstruction lawsuit in louisiana diarrhea law firm semaglutide diarrhea law firm in louisiana kentucky semaglutide gastrointestinal lawyer Wegovy® Lawsuit-150cent-mvanhaasteren.nl SURGE IN GLP-1 DRUGS LIKE

Retatrutide, a TRIPLE agonist (GLP1, GIP, glucagon), just released phase 2 trial results demonstrating 25% weight loss in half of people with #obesity

Once mechanical obstruction is excluded, gastric scintigraphy remains the gold standard for diagnosis although wireless motility capsule and breath testing are alternative methods for diagnosis

Learn how medically supervised weight loss with GLP-1 therapy at Lorton Medical Spa can support effective appetite control, sustainable fat reduction, and healthier outcomes using evidence-based treatments.

This systematic review and meta-analysis aims to update the evidence on the impact of GLP-1 RAs on EGD outcomes, evaluate the effect of concurrent colonoscopy (CLN) on GRC, and assess the influence of different GLP-1 RA agents on GRC

Adults with obesity who reported more intense tastes while receiving semaglutide or tirzepatide had a higher likelihood for increased satiety and decreased appetite and food cravings, according to a presenter

The Truth About GLP-1s, provided an overview of GLP-1s and their role in the current weight-management industry